Redcare Pharmacy stock gains on fresh analyst support
Published on 09/20/2026 at 13:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Redcare Pharmacy stock (ISIN NL0012044747) traded at EUR 60.90 on Xetra on September 18, 2026, after a 1.67 percent rise on the day. The move came as Deutsche Bank Research kept its Buy rating at EUR 103 on September 1, 2026, and Jefferies reiterated Buy at EUR 97 on September 3, 2026.
Analysts keep the upside open
According to ad hoc news, Deutsche Bank Research set the target at EUR 103 on September 1, 2026, while the same report says Jefferies kept a Buy call with EUR 97 on September 3, 2026. The gap to the September 18 close of EUR 60.90 is 69.2 percent versus Deutsche Bank and 59.3 percent versus Jefferies.
As The Globe and Mail reported on September 20, 2026, the Street consensus stood at Strong Buy with an average price target of EUR 91.67. The same note said the shares closed at EUR 61.07 yesterday.
Trading stays below the targets
The market level of EUR 60.90 leaves Redcare Pharmacy below the EUR 91.67 consensus target and far under the EUR 97 and EUR 103 house views. For investors, the distance to those targets is the clearest signal in the stock right now.
According to ad hoc news, the stock was around EUR 60.90 on September 18, 2026, and the same overview described the shares as actively traded in SDAX. The quote sits far above the recent low of the mid-60 euro zone?
